• News/ 
  • Latest news

News

21.10.2011 Chiesi unveils new R&D Center in Parma

Faced with international competition and growing pressures in Europe due to cuts in national health budgets, Chiesi appeard to beat industry trends by announcing double-digit growth in 2010 and opening of a new Euro 90 mio...


23.05.2011 Company name change announcement „Chiesi Pharmaceuticals“

We recently went through a company name change. As of May 14, 2011 the new company name is Chiesi Pharmaceuticals. This is a highly significant move and shows the completition and full integration into the Chiesi group.

10...


19.04.2011 Chiesi Group´s financial statement 2010 approved: sales exceed one billion euro

The Board of Directors approved the draft financial statements for 2010; sales exceed one billion euro

The positive trend in performance continued with consolidated revenue of € 1,015 billion, up by 16.4% compared with 2009 and...


15.03.2011 TRACE International renews Chiesi Pharmaceuticals´ membership

TRACE International Inc. (TRACE) has completed a TRACE Standard due diligence review of Chiesi Pharmaceuticals GmbH.  TRACE has granted Chiesi Pharmaceuticals GmbH a certificate of membership signifying the company’s...


24.02.2011 Takeback of Curosurf® in Russia and CIS

Curosurf® will be marketed in the territory of Russia and some countries of the CIS by Chiesi starting February 19, 2011. During the past years it was licensed out to a partner company.

Curosurf®, developed by Chiesi...


16.08.2010 Rapydan® patch for surface anesthesia

Rapydan® is a medicated plaster (70 mg lidocain and 70 mg tetracaine) used for surface anesthesia of the skin in connection with needle puncture on normal intact skin in adults and in children from 3 years of age as well as for...


05.07.2010 Chiesi Farmaceutici turns 75 and looks toward the future

The dream of a pharmacist from a small town becomes reality. This is the story of Chiesi Farmaceutici, which today is celebrating its 75th anniversary and looking toward the future with ever stronger entrepreneurial esprit. From...


07.04.2010 Chiesi Group - Total sales increased by 16,5% in 2009

A positive 2009 for the Chiesi Group, which confirms and further improves the growth trend recorded over the last few years, both in Italy and internationally. Sales reached € 872 million with a growth of 16,5% in 2008,...


01.03.2010 TRACE International certified Torrex Chiesi Pharma GmbH

TRACE International Inc. (TRACE) has successfully completed a TRACE Standard due diligence review of Torrex Chiesi Pharma GmbH.  TRACE has granted Torrex Chiesi Pharma GmbH a certificate of membership signifying the...


19.11.2009 Chiesi Farmaceutici is top Italian pharmaceutical group for investments in research

Ranking on eighth place in Italy